Location History:
- Quebec, CA (2010)
- Longueil, CA (2012 - 2014)
- Longueuil, CA (2009 - 2016)
Company Filing History:
5 out of 22 
2 out of 24 
1 out of 1 Years Active: 2009-2016
Title: The Innovative Contributions of Scott Jarvis
Introduction
Scott Jarvis is a notable inventor based in Longueuil, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating proliferative disorders such as cancer. With a total of eight patents to his name, Jarvis has established himself as a key figure in medical innovation.
Latest Patents
Among his latest patents are the IAP BIR domain binding compounds. These patents include a compound of Formula 1, or a salt thereof, along with methods for making these compounds. Additionally, he has developed methods for using these compounds to treat proliferative disorders, including cancer. Another patent focuses on an isomer, enantiomer, diastereoisomer, or tautomer of a compound represented by Formula I, which may also include a prodrug or a pharmaceutically acceptable salt. These innovations highlight his commitment to advancing medical treatments.
Career Highlights
Throughout his career, Scott Jarvis has worked with prominent companies in the pharmaceutical industry, including Pharmascience Inc. and Aegera Therapeutics, Inc. His work has been instrumental in the development of new therapeutic strategies, showcasing his expertise and dedication to improving patient outcomes.
Collaborations
Jarvis has collaborated with several professionals in his field, including James B. Jaquith and Alain Laurent. These partnerships have contributed to the success of his projects and the advancement of his research.
Conclusion
Scott Jarvis is a distinguished inventor whose work in the pharmaceutical sector has led to significant advancements in cancer treatment. His innovative patents and collaborations reflect his commitment to improving healthcare through scientific research.